|
Background
|
Anterior gradient 2 (AGR2) is known as a cancer cell marker specifically up-regulated in response to depletion of serum and oxygen. AGR2 has been identified as a tumor marker in primary and secondary cancer lesions, and as a marker for detection of circulating tumor cells (CTCs). Elevated levels of AGR2 are known to increase the metastatic potential of cancer cells, but conditions leading to increased expression of AGR2 are not well understood.
|
Background
References
|
- Zweitzig,D.R., Mol. Cell. Biochem. 306 (1-2), 255-260 (2007)
- Zhang,Y., Prostate Cancer Prostatic Dis. 10 (3), 293-300 (2007)
- Fletcher,G.C., Br. J. Cancer 88 (4), 579-585 (2003)
|
Order Information
List Price (USA): $235.00/0.1mg
Related Products
Data Rewards Program
